The recent recognition of three Harvard scientists at the prestigious Breakthrough Prizes highlights significant strides in the fields of gene editing, multiple sclerosis research, and obesity treatment.Harvard faculty members Alberto Ascherio, Joel Habener, and David Liu were spotlighted among the elite honorees, akin to the "Oscars of Science." Ascherio’s pioneering work on the Epstein-Barr virus has uncovered its crucial role in the onset of multiple sclerosis, a revelation that opens pathways for innovative therapies.